Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of nosocomial infections in hospitalized adult patients, especially those who remain in critical care units for extended periods of time (22) . While S. aureus is the most frequently reported nosocomial pathogen on pediatric and newborn services in large hospitals, resistance to methicillin is uncommon (11) . The few reported outbreaks of MRSA involving colonization and infection of pediatric patients have been characterized by high rates of morbidity and mortality (6, 22) . This has been attributed in part to the rapidity with which the organism spreads in a hospital unit and the propensity for these organisms to be resistant to multiple antibiotics (7, 12) .
Control of the spread of MRSA in a hospital relies upon the timely identification of these organisms in the patient population and then the immediate institution of appropriate infection control methods (18, 25) . Rapid and accurate identification of the species of Staphylococcus involved is critical, since the control measures implemented will vary depending on the identity of the outbreak organism. A rapid method commonly used by hospital microbiology laboratories to differentiate S. aureus from other staphylococcal species is latex agglutination. In this assay, latex particles coated with fibrinogen and immunoglobulin G are used to detect protein A and/or clumping factor on the cell surface of S. aureus (19) . Questions have been raised as to the utility of * Corresponding author. this test in identifying MRSA since decreased sensitivity has been reported (20, 24) .
This report describes an outbreak of clindamycin-susceptible, latex agglutination-negative MRSA among infants in a newborn special care unit (NBSC) and newborn intensive care unit (TNIC) Genomic DNA analysis by PFGE. Genomic DNA was prepared as described by Murray et al. (15) , with minor modifications. Briefly, the staphylococci were grown overnight in brain heart infusion broth at 37°C. Pelleted cells were resuspended in 1 M NaCl-10 mM Tris hydrochloride (pH 7.6) mixed with low-melting-temperature agarose (In Cert Agarose; FMC Corp.) and were put into plug forms. The agarose plugs were added to lysis solution (6 mM Tris hydrochloride [pH 7.6], 1 M NaCl, 100 mM EDTA [pH 7.5], 0.5% Brij 58, 0.2% deoxycholate, 0.5% sodium lauroyl sarcosine, 20 pug of RNase per ml, 30 U of lysostaphin per ml) and were incubated overnight at 37°C. Lysis was continued overnight by incubation at 50°C in ESP solution (0.5 mM EDTA [pH 9 to 9.5], 1% sodium lauroyl sarcosine, 50 p,g of proteinase K per ml). After thorough washing with 10 mM Tris hydrochloride (pH 7.5)-0.1 mM EDTA, plugs were digested with SmaI and electrophoresed by pulsed-field gel electrophoresis (PFGE; Bio-Rad CHEF DR II).
RESULTS
Epidemiological investigation. The NBSC is physically divided into two sections, each containing 14 to 18 beds and supervised by 46 to 50 staff members who circulate between the two sections. The children range in age from newborn to approximately 6 months and have minimal interaction with non-staff personnel because of limited access of non-staff personnel to the unit. The TNIC has approximately 12 to 15 beds, supervision is by 20 to 25 staff members, and the age range and non-staff member interactions are as stated above. Figure 1 shows the number of newborns colonized or infected with MRSA (in both the NBSC and TNIC) during 1989 and 1990. MRSA was cultured from samples from the nares, groin, or umbilicus of seven (20%) of the newborns in the NBSC during January 1989. One of the culture-positive infants had been transferred from another hospital in Houston and was felt to be the index case, although definitive evidence is lacking. Prior to that time, colonization with MRSA had not been found in the NBSC. Following the identification of four MRSA-infected newborns in the TNIC and two in the NBSC in May and June of 1989, additional samples for surveillance cultures were obtained from newborns in both units. Again, the extent of MRSA colonization was approximately 20% in each unit. For surveillance cultures of staff members, samples from personnel working in either unit during June 1989 revealed MRSA in the nares of 4 of 62 personnel members in the NBSC and 0 of 52 staff members in the TNIC. Follow-up samples from staff members after chemotherapeutic decolonization were negative for MRSA on culture. Continued surveillance culturing was used in order to monitor the colonization rate of newborns in each unit.
Despite aggressive enforcement of maintaining colonized and infected infants in cohorts and strict enforcement of hand-washing procedures, follow-up surveillance in February 1990 once again revealed that 2 infants in the TNIC and 10 infants in the NBSC were colonized with MRSA. At that time, samples from the nares of all personnel entering either newborn unit (including students, nurses, and primary and consulting physicians) were cultured. Of the 324 personnel from whom samples for culture were obtained, 5 were found to have nasal MRSA colonization. Colonized individuals were treated orally with trimethoprim-sulfamethoxazole and rifampin, and cultures of samples from all individuals were negative upon repeat culturing at 3 weeks posttreatment.
Concurrent with the decolonization efforts, a strict handwashing and mandatory glove-wearing policy was instituted for all personnel having contact with newborns in the units. Subsequent surveillance surveys in April 1990 identified no colonized newborns in the TNIC.
Laboratory investigations. All the MRSA isolates from patients and personnel were noted to be unreactive by both latex agglutination and slide coagulase analyses and were subsequently identified as S. aureus on the basis of colony morphology, tube coagulase reactivity, and DNase activity. All of these isolates produced identical disk diffusion susceptibility results and were unique among other MRSA isolated in the hospital in that they were susceptible to clindamycin. Since the isolates shared two unusual characteristics (latex nonreactivity and clindamycin susceptibility), attempts were made to determine their relatedness by using several epidemiological methods, including antibiogram, bacteriophage typing, capsular serotyping, and DNA analysis. During the course of our study, two other hospitals in Houston reported the isolation of MRSA from pediatric patients; the isolates proved to be phenotypically identical to our strains and were, henceforth, included in our studies.
Broth microdilution MICs of a panel of 24 antibiotics were determined for 12 isolates recovered from the seven infants found to be colonized in January 1989 (samples from multiple sites were cultured for some infants). The results confirmed the susceptibilities of the isolates to clindamycin, giving further evidence of their relatedness. Results for all other antibiotics were identical except for a few minor differences (Table 1) .
Staphylococcal bacteriophage typing demonstrated that the majority of isolates were nontypeable. Capsular polysaccharide typing revealed that 14 of 30 isolates were reactive with monoclonal antibodies to capsular polysaccharide serotype 5. Fournier and colleagues (9) have shown that MRSA which were nonreactive in latex agglutination assays were of capsular serotype 5.
Plasmid pattern analysis revealed a single plasmid with an approximate molecular weight of 100 kb in each of the MRSA isolates (Fig. 2) . Restriction enzyme digestion of these plasmids demonstrated patterns which again suggested their relatedness (data not shown). Plasmid pattern analysis of 30 MRSA strains recovered from adult patients in the same hospital revealed the presence of multiple plasmids, none of which resembled the pattern found in the isolates from the NBSC (data not shown). All MRSA isolates from the NBSC and TNIC as well as those from pediatric patients in two other hospitals in Houston proved to be identical by using PFGE to compare restriction digests of genomic DNAs (Fig. 3) . One of those two hospitals was the source of the transferred infant who was presumed to be the index case of the outbreak. The patterns that these isolates exhibited by PFGE were, however, distinct from those seen with isolates of MRSA collected from other patients within the same hospital.
DISCUSSION
An unusual strain of MRSA was isolated from pediatric patients in an NBSC in January 1989. Despite the significant occurrence of MRSA in adult patients in the critical care units of this same hospital (4), it has been absent from the NBSC prior to that time. While estimates of the colonization rates of MRSA in hospitals that serve neonates and pediatric patients are not available, few outbreaks of MRSA in neonatal intensive care units have been reported (6, 11, 22) . 
' AM, ampicillin; CFM, cefamandole; CFZ, cefazolin; CX, cefoxitin; CFX, cefuroxime; CL, cephalothin; C, chloramphenicol; CIP, ciprofloxacin; CC,
clindamycin; E, erythromycin; GM, gentamicin; OX, oxacillin; P, penicillin; RF, rifampin; SSS, triple sulfa; TE, tetracycline; TS, trimethoprim-sulfamethoxazole; NN, tobramycin; VA, vancomycin; R, resistant; S, susceptible; MS, moderately susceptible.
Isolates from the NBSC were nonreactive in the latex agglutination assay routinely used by our clinical laboratory for the identification of S. aureus. Despite this nonreactivity, colony morphology and hemolytic reactivity on trypticase soy agar with 5% sheep erythrocytes prompted laboratory personnel to perform further tests and thus accurately identify the organism as S. aureus. Even so, it is impossible to rule out the existence of MRSA in the NBSC prior to January 1989, since incorrect identification of isolates by latex agglutination could have masked its presence. The organism's antibiogram, however, was recognized as not being typical of the hospital's nosocomial strains of staphylococci. Moreover, in a 1988 in-house evaluation of latex agglutination versus tube coagulase testing for the identification of clinical isolates of S. aureus, including MRSA, latex agglutination showed a sensitivity of >95% (unpublished data). This evidence suggests the absence of the latex agglutination-negative strain in the NBSC before the outbreak. Nonetheless, the lower sensitivities of latex aggluti- (19, 20, 24) .
The MRSA strains from the NBSC were susceptible to clindamycin, a finding not frequently seen in MRSA isolates in our hospital. In a recent review of MRSA in pediatric patients, Kline and Mason (12) described a number of isolates from pediatric patients as being resistant to multiple antibiotics, including erythromycin and clindamycin. In contrast, a case report of pediatric community-acquired MRSA described an isolate that was susceptible to clindamycin by microdilution susceptibility testing. The patient was treated with clindamycin, with good clinical results and a bactericidal titer in serum of >1:128 (21) . Current recommendations, however, do not include clindamycin as an empirically useful agent for the treatment of MRSA infections (7) .
After isolating the unusual strain of MRSA from our NBSC, we learned of two other hospitals in the city which had also recovered MRSA from pediatric patients. Those strains were nonreactive by latex agglutination and were susceptible to clindamycin. Initial attempts at comparing the isolates from the NBSC with each other and with the isolates collected from the other hospitals by bacteriophage typing 
